Study of Digoxin as inhibitor of the in vivo effects of acetyl glyceryl ether phosphorycholine (AGEPC) in mice
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (6), 623-633
- https://doi.org/10.1016/0024-3205(88)90453-5
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effect of non-steroidal anti-inflammatory drugs on alkyl-acetyl-glycerol-phosphorylcholine-induced anaphylactic shock in miceBiochemical Society Transactions, 1986
- Effects of digitalis on the normal and the failing heartJournal of the American College of Cardiology, 1985
- Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs.JCI Insight, 1984
- Pathophysiological mechanisms of sudden death induced by platelet activating factorBritish Journal of Pharmacology, 1984
- Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig.Circulation Research, 1984
- 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholines: Influence on aggregation and [3H] serotonin release of human thrombocytesChemistry and Physics of Lipids, 1983
- Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbitImmunopharmacology, 1983
- Mechanism of Action of Calcium-Channel-Blocking AgentsNew England Journal of Medicine, 1982
- Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholineBiochemical and Biophysical Research Communications, 1982
- Human platelet activation by an alkylacetyl analogue of phosphatidylcholineBiochimica et Biophysica Acta (BBA) - General Subjects, 1982